S. Akira, Y. Nishio, M. Inoue, X. J. Wang, and S. Wei, Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway, Cell, vol.77, p.7512451, 1994.

N. M. Mackey-lawrence, W. A. Petri, and J. , Leptin and mucosal immunity, Mucosal immunology, vol.5, p.22692456, 2012.

A. F. Wilks, A. G. Harpur, R. R. Kurban, S. J. Ralph, and G. Zurcher, Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase, Molecular and cellular biology, vol.11, p.1848670, 1991.

S. G. Rane and E. P. Reddy, JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells, Oncogene, vol.9, p.7518579, 1994.

I. Firmbach-kraft, M. Byers, T. Shows, R. Dalla-favera, and J. J. Krolewski, ) tyk2, prototype of a novel class of non-receptor tyrosine kinase genes, Oncogene, vol.5, p.2216457, 1990.

A. Kaptein, V. Paillard, and M. Saunders, Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction, The Journal of biological chemistry, vol.271, p.8626374, 1996.

G. M. Delgoffe and D. A. Vignali, STAT heterodimers in immunity: A mixed message or a unique signal, JAK-STAT, vol.2, p.24058793, 2013.

Z. Wen, Z. Zhong, and J. E. Darnell, Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation, Cell, vol.82, p.7543024, 1995.

J. Wegrzyn, R. Potla, Y. J. Chwae, N. B. Sepuri, and Q. Zhang, Function of mitochondrial Stat3 in cellular respiration, Science, vol.323, p.19131594, 2009.

Z. L. Yuan, Y. J. Guan, D. Chatterjee, and Y. E. Chin, Stat3 dimerization regulated by reversible acetylation of a single lysine residue, Science, vol.307, p.15653507, 2005.

J. Yang, J. Huang, M. Dasgupta, N. Sears, and M. Miyagi, Reversible methylation of promoterbound STAT3 by histone-modifying enzymes, Proceedings of the National Academy of Sciences of the United States of America, vol.107, p.21098664, 2010.

V. Kumar, P. Cheng, T. Condamine, S. Mony, and L. R. Languino, CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation, Immunity, vol.44, p.26885857, 2016.

S. Veeriah, C. Brennan, S. Meng, B. Singh, and J. A. Fagin, The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers, Proceedings of the National Academy of Sciences of the United States of America, vol.106, p.19478061, 2009.

X. Zhang, A. Guo, J. Yu, A. Possemato, and Y. Chen, Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T, Proceedings of the National Academy of Sciences of the United States of America, vol.104, p.17360477, 2007.

D. Lu, L. Liu, J. X. Gao, Y. Chen, and X. , The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation, Nature immunology, vol.16, p.26479789, 2015.

S. E. Nicholson, D. Souza, D. Fabri, L. J. Corbin, J. Willson et al., Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130, Proceedings of the National Academy of Sciences of the United States of America, vol.97, p.10829066, 2000.

A. Sasaki, H. Yasukawa, A. Suzuki, S. Kamizono, and T. Syoda, Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain, Genes to cells: devoted to molecular & cellular mechanisms, vol.4, pp.339-351, 1999.

J. Lupberger, F. H. Duong, I. Fofana, Z. L. Xiao, and F. , Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha, Hepatology, vol.58, p.23519785, 2013.

L. Icardi, R. Mori, V. Gesellchen, S. Eyckerman, D. Cauwer et al., The Sin3a repressor complex is a master regulator of STAT transcriptional activity, Proceedings of the National Academy of Sciences of the United States of America, vol.109, p.22783022, 2012.

L. B. Ivashkiv and L. T. Donlin, Regulation of type I interferon responses, Nat Rev Immunol, vol.14, p.24362405, 2014.

M. H. Heim, Signaling pathways in liver diseases, pp.214-225, 2015.

M. Karin and H. Clevers, Reparative inflammation takes charge of tissue regeneration, Nature, vol.529, p.26791721, 2016.

G. K. Michalopoulos, Principles of liver regeneration and growth homeostasis, Comprehensive Physiology, vol.3, p.23720294, 2013.

G. K. Michalopoulos, Advances in liver regeneration, Expert review of gastroenterology & hepatology, vol.8, pp.897-907, 2014.

M. W. Robinson, C. Harmon, O. 'farrelly, and C. , Liver immunology and its role in inflammation and homeostasis, Cellular & molecular immunology, vol.13, pp.267-276, 2016.

N. Selzner, M. Selzner, B. Odermatt, Y. Tian, and N. Van-rooijen, ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice, Gastroenterology, vol.124, p.12612908, 2003.

G. K. Michalopoulos, Liver regeneration, Journal of cellular physiology, vol.213, p.17559071, 2007.

H. Yu, H. Lee, A. Herrmann, R. Buettner, and R. Jove, Revisiting STAT3 signalling in cancer: new and unexpected biological functions, Nature reviews Cancer, vol.14, p.25342631, 2014.

S. M. Holland, F. R. Deleo, H. Z. Elloumi, A. P. Hsu, and G. Uzel, STAT3 mutations in the hyper-IgE syndrome, The New England journal of medicine, vol.357, p.17881745, 2007.

A. M. Siegel, J. Heimall, A. F. Freeman, A. P. Hsu, and E. Brittain, A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory, Immunity, vol.35, p.22118528, 2011.

G. Waris and A. Siddiqui, Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function, J Virol, vol.76, p.11861839, 2002.

Y. H. Lee and Y. Yun, HBx protein of hepatitis B virus activates Jak1-STAT signaling, J Biol Chem, vol.273, p.9738022, 1998.

K. Yuan, Y. Lei, H. N. Chen, Y. Chen, and T. Zhang, HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3, Cell Death Differ, vol.23, p.26794444, 2016.

E. M. Mccartney, K. J. Helbig, S. K. Narayana, N. S. Eyre, and A. L. Aloia, Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus, Hepatology, vol.58, p.23703790, 2013.

T. Yoshida, T. Hanada, T. Tokuhisa, K. Kosai, and M. Sata, Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation, The Journal of experimental medicine, vol.196, p.12208879, 2002.

G. Gong, G. Waris, R. Tanveer, and A. Siddiqui, Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B, Proc Natl Acad Sci U S A, vol.98, p.11481452, 2001.

C. Pinkham, S. An, L. Lundberg, N. Bansal, and A. Benedict, The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection, Virology, vol.496, p.27318793, 2016.

E. Slinger, D. Maussang, A. Schreiber, M. Siderius, and A. Rahbar, HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis, Sci Signal, vol.3, p.20682912, 2010.

Q. Lepiller, W. Abbas, A. Kumar, M. K. Tripathy, and G. Herbein, HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes, PLoS ONE, vol.8, p.23555719, 2013.

S. V. Kotenko, S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka, Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10), Proc Natl Acad Sci U S A, vol.97, p.10677520, 2000.

M. J. Raftery, D. Wieland, S. Gronewald, A. A. Kraus, and T. Giese, Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10, J Immunol, vol.173, p.15322202, 2004.

J. V. Spencer, The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes, J Virol, vol.81, p.17121792, 2007.

H. Chen, L. Hutt-fletcher, L. Cao, and S. D. Hayward, A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus, J Virol, vol.77, p.12634372, 2003.

C. P. Kung, D. G. Meckes, and N. Raab-traub, Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta, J Virol, vol.85, p.21307189, 2011.

R. Muromoto, O. Ikeda, K. Okabe, S. Togi, and S. Kamitani, Epstein-Barr virus-derived EBNA2 regulates STAT3 activation, Biochem Biophys Res Commun, vol.378, p.19032945, 2009.

K. W. Moore, P. Vieira, D. F. Fiorentino, M. L. Trounstine, and T. A. Khan, Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI, Science, vol.248, p.2161559, 1990.

Y. Ding, L. Qin, S. V. Kotenko, S. Pestka, and J. S. Bromberg, A single amino acid determines the immunostimulatory activity of interleukin 10, J Exp Med, vol.191, p.10637267, 2000.

X. Wan, H. Wang, and J. Nicholas, Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6, J Virol, vol.73, p.10482577, 1999.

R. Santarelli, R. Gonnella, D. Giovenale, G. Cuomo, L. Capobianchi et al., STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells, Sci Rep, vol.4, p.24577500, 2014.

N. Sen, C. X. Rajamani, J. Zerboni, L. Sung, and P. , Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis, Proc Natl Acad Sci U S A, vol.109, p.22190485, 2012.

J. J. Docherty, T. J. Sweet, E. Bailey, S. A. Faith, and T. Booth, Resveratrol inhibition of varicella-zoster virus replication In vitro, Antiviral Res, vol.72, p.16899306, 2006.

S. Zhu, H. Luo, H. Liu, Y. Ha, and E. R. Mays, plays a critical role in induction of a proinflammatory phenotype of retinal Muller cells following Zika virus infection, Antiviral Res, vol.145, p.28739278, 2017.

M. Aid, P. Abbink, R. A. Larocca, M. Boyd, and R. Nityanandam, Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys, Cell, vol.169, p.28457610, 2017.

C. M. Ulane, J. J. Rodriguez, J. P. Parisien, and C. M. Horvath, STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling, J Virol, vol.77, p.12743296, 2003.

H. Palosaari, J. P. Parisien, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath, STAT protein interference and suppression of cytokine signal transduction by measles virus V protein, J Virol, vol.77, pp.7635-7644, 2003.

K. P. Hui, H. S. Li, M. C. Cheung, R. W. Chan, and K. M. Yuen, Highly pathogenic avian influenza H5N1 virus delays apoptotic responses via activation of STAT3, Sci Rep, vol.6, p.27344974, 2016.

D. Jia, R. Rahbar, R. W. Chan, S. M. Lee, and M. C. Chan, Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling, PLoS ONE, vol.5, p.21085662, 2010.

V. Chandra, A. Kar-roy, S. Kumari, S. Mayor, and S. Jameel, The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response, J Virol, vol.82, p.18448545, 2008.

K. G. Lieu, A. Brice, L. Wiltzer, B. Hirst, and D. A. Jans, The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling, J Virol, vol.87, p.23698294, 2013.

D. N. Mitzel, R. J. Jaramillo, H. Stout-delgado, A. P. Senft, and K. S. Harrod, Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium, J Gen Virol, vol.95, p.24114793, 2014.

J. M. Reitsma, H. Sato, M. Nevels, S. S. Terhune, and C. Paulus, Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus, J Virol, vol.87, p.23903834, 2013.

D. Ramalingam and J. M. Ziegelbauer, Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses. Sci Rep, vol.7, p.28102325, 2017.

L. Li, H. C. Chong, S. Y. Ng, K. W. Kwok, and Z. Teo, Angiopoietin-like 4 Increases Pulmonary Tissue Leakiness and Damage during Influenza Pneumonia, Cell Rep, 2015.

M. Kane and T. Golovkina, Common threads in persistent viral infections, J Virol, vol.84, pp.4116-4123, 2010.

P. Danthi, Viruses and the Diversity of Cell Death, Annu Rev Virol, vol.3, p.27501259, 2016.

H. Yu, M. Kortylewski, and D. Pardoll, Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment, Nat Rev Immunol, vol.7, p.17186030, 2007.

S. Koganti, C. Clark, J. Zhi, X. Li, and E. I. Chen, Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes, J Virol, vol.89, p.25717101, 2015.

C. A. King, X. Li, A. Barbachano-guerrero, and S. Bhaduri-mcintosh, STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus, J Virol, vol.89, p.26339061, 2015.

D. Zhang, M. Sun, D. Samols, and I. Kushner, STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6, J Biol Chem, vol.271, p.8621622, 1996.

D. Lv, Y. Zhang, H. J. Kim, L. Zhang, and X. Ma, CCL5 as a potential immunotherapeutic target in triple-negative breast cancer, Cell Mol Immunol, vol.10, p.23376885, 2013.

F. Halary, A. A. Lortat-jacob, H. Messerle, M. Delaunay, and T. , Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection, Immunity, vol.17, p.12433371, 2002.
URL : https://hal.archives-ouvertes.fr/hal-01061427

E. C. Shin, P. S. Sung, and S. H. Park, Immune responses and immunopathology in acute and chronic viral hepatitis, Nat Rev Immunol, vol.16, p.27374637, 2016.

J. P. Ren, L. Wang, J. Zhao, S. B. Ning, E. Gazzar et al., Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection, Immunology, vol.150, p.27753084, 2017.

N. Zhai, H. Li, H. Song, Y. Yang, and A. Cui, Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling, PLoS ONE, vol.12, p.28114346, 2017.

S. Wan, N. Kuo, I. Kryczek, W. Zou, and T. H. Welling, Myeloid cells in hepatocellular carcinoma, Hepatology, vol.62, p.25914264, 2015.

B. Wolk, B. Buchele, D. Moradpour, and C. M. Rice, A dynamic view of hepatitis C virus replication complexes, J Virol, vol.82, p.18715913, 2008.

F. Roohvand, P. Maillard, J. P. Lavergne, S. Boulant, and M. Walic, Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein, J Biol Chem, vol.284, p.19269968, 2009.

J. M. Llovet, J. Zucman-rossi, E. Pikarsky, B. Sangro, and M. Schwartz, Hepatocellular carcinoma, p.27158749, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01910322

Y. Ho, S. W. Tsao, M. Zeng, and V. W. Lui, STAT3 as a therapeutic target for Epstein-Barr virus (EBV): associated nasopharyngeal carcinoma, Cancer Lett, vol.330, p.23220625, 2013.

V. W. Lui, E. Y. Wong, Y. Ho, B. Hong, and S. C. Wong, STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells In vitro, Int J Cancer, vol.125, p.19588483, 2009.

S. Kondo, T. Yoshizaki, N. Wakisaka, T. Horikawa, and S. Murono, MUC1 induced by EpsteinBarr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling, J Virol, vol.81, p.17151127, 2007.

A. Wong, J. L. Hirpara, S. Pervaiz, J. Q. Eu, and G. Sethi, Do STAT3 inhibitors have potential in the future for cancer therapy?, Expert Opin Investig Drugs, vol.26, p.28714740, 2017.

Y. Niu, Y. Si, Y. Li, C. X. Li, and X. , A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3, J Antimicrob Chemother, vol.70, p.25858355, 2015.

Y. Yang, B. Zheng, Q. Han, C. Zhang, and Z. Tian, Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma, Cancer Biol Ther, vol.17, p.26934469, 2016.

G. Miklossy, T. S. Hilliard, and J. Turkson, Therapeutic modulators of STAT signalling for human diseases, Nat Rev Drug Discov, vol.12, p.23903221, 2013.

J. L. Espinoza, A. Takami, L. Q. Trung, S. Kato, and S. Nakao, Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells, PLoS ONE, vol.7, p.23251493, 2012.

D. Leo, A. Arena, G. Lacanna, E. Oliviero, G. Colavita et al., Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets, Antiviral Res, vol.96, p.22985630, 2012.

C. L. Liu, H. C. Hung, S. C. Lo, C. H. Chiang, and I. J. Chen, Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development, Sci Rep, vol.6, p.21662, 2016.

K. Kim, K. H. Kim, H. Y. Kim, H. K. Cho, and N. Sakamoto, Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway, FEBS Lett, vol.584, pp.707-712, 2010.

M. Michaelis, C. Paulus, N. Loschmann, S. Dauth, and E. Stange, The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication, Cell Mol Life Sci, vol.68, p.20803231, 2011.

S. L. Furtek, D. S. Backos, C. J. Matheson, and P. Reigan, Strategies and Approaches of Targeting STAT3 for Cancer Treatment, ACS Chem Biol, vol.11, p.26730496, 2016.

H. Gharwan and H. Groninger, Kinase inhibitors and monoclonal antibodies in oncology: clinical implications, Nat Rev Clin Oncol, vol.13, p.26718105, 2016.

L. N. Heppler and D. A. Frank, Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors, Trends Cancer, vol.3, p.29198438, 2017.

J. Baell and M. A. Walters, Chemistry: Chemical con artists foil drug discovery, Nature, vol.513, p.25254460, 2014.

. Clinicaltrials and . Gov, AZD9150 With MEDI4736 in Patients With Advanced Pancreatic, Non-Small Lung and Colorectal Cancer, 2017.

. Clinicaltrials and . Gov, Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL, 2017.

. Clinicaltrials and . Gov, Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck, 2017.

J. M. Hubbard and A. Grothey, Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor, Drugs, vol.77, p.28573435, 2017.